Literature DB >> 6026689

Susceptibility of Mycoplasma pneumoniae to 21 antibiotics in vitro.

R L Jao.   

Abstract

Mesh：

Substances：

Year:  1967        PMID： 6026689     DOI： 10.1097/00000441-196706000-00001

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  17 in total

1.  Antibiotic sensitivities in vitro of diverse spiroplasma strains associated with plants and insects.

Authors:  R E Davis
Journal:  Appl Environ Microbiol       Date:  1981-01       Impact factor: 4.792

2.  Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin.

Authors:  G E Kenny; F D Cartwright
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

3.  Standardized methods and quality control limits for agar and broth microdilution susceptibility testing of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum.

Authors:  Ken B Waites; Lynn B Duffy; Cécile M Bébéar; Anne Matlow; Deborah F Talkington; George E Kenny; Patricia A Totten; Donald J Bade; Xiaotian Zheng; Maureen K Davidson; Virginia D Shortridge; Jeffrey L Watts; Steven D Brown
Journal:  J Clin Microbiol       Date:  2012-08-22       Impact factor: 5.948

4.  A symposium on the tetracyclines: a major appraisal. Introduction.

Authors:  H C Neu
Journal:  Bull N Y Acad Med       Date:  1978-02

5.  In vitro development of resistance to erythromycin, other macrolide antibiotics, and lincomycin in Mycoplasma pneumoniae.

Authors:  Y Nitu; S Hasegawa; H Kubota
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

Review 6.  Mycoplasmas and cell cultures.

Authors:  E Stanbridge
Journal:  Bacteriol Rev       Date:  1971-06

Review 7.  Infectious diseases. Annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1968-07       Impact factor: 2.401

8.  Possible influence of antibiotic therapy on usefulness of metabolic inhibition test for diagnosis of Mycoplasma pneumoniae infections.

Authors:  T F Smith; E C Herrmann
Journal:  Appl Microbiol       Date:  1971-01

9.  [Tissue penetration of erythromycin (author's transl)].

Authors:  G A Dette
Journal:  Infection       Date:  1979       Impact factor: 3.553

10.  Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.

Authors:  G E Kenny; F D Cartwright
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.